A detailed history of Federated Hermes, Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,351,880 shares of CDXS stock, worth $4.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,351,880
Previous 1,340,430 0.85%
Holding current value
$4.57 Million
Previous $4.09 Million 15.41%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$2.59 - $4.65 $29,655 - $53,242
11,450 Added 0.85%
1,351,880 $4.72 Million
Q4 2023

Jan 31, 2024

SELL
$1.54 - $3.37 $88,705 - $194,115
-57,601 Reduced 4.12%
1,340,430 $4.09 Million
Q3 2023

Nov 13, 2023

SELL
$1.5 - $3.75 $1.69 Million - $4.23 Million
-1,127,034 Reduced 44.63%
1,398,031 $2.64 Million
Q2 2023

Aug 14, 2023

BUY
$2.21 - $4.43 $4.51 Million - $9.03 Million
2,038,716 Added 419.19%
2,525,065 $7.07 Million
Q1 2023

May 08, 2023

SELL
$3.81 - $6.76 $633,823 - $1.12 Million
-166,358 Reduced 25.49%
486,349 $2.01 Million
Q4 2022

Feb 13, 2023

BUY
$4.26 - $6.84 $2.78 Million - $4.46 Million
652,707 New
652,707 $3.04 Million
Q1 2022

May 13, 2022

SELL
$16.97 - $31.93 $160,790 - $302,536
-9,475 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $242,654 - $395,865
9,475 New
9,475 $296,000
Q2 2019

Aug 14, 2019

SELL
$17.0 - $21.88 $846,838 - $1.09 Million
-49,814 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$15.53 - $22.15 $2.58 Million - $3.67 Million
-165,809 Reduced 76.9%
49,814 $1.02 Million
Q4 2018

Feb 13, 2019

SELL
$14.06 - $22.57 $3.86 Million - $6.2 Million
-274,581 Reduced 56.01%
215,623 $3.6 Million
Q3 2018

Nov 13, 2018

BUY
$13.35 - $19.1 $6.54 Million - $9.36 Million
490,204 New
490,204 $8.41 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $221M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.